Immediate Impact
5 from Science/Nature 62 standout
Citing Papers
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
Works of Michael S. Henson being referenced
A phase I clinical study to evaluate safety of orally administered, genetically engineeredSalmonella entericaserovarTyphimuriumfor canine osteosarcoma
2016
Feline Models of Type 2 Diabetes Mellitus
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael S. Henson | 213 | 197 | 67 | 125 | 26 | 516 | |
| Glen K. King | 82 | 277 | 25 | 103 | 16 | 506 | |
| Kaitlin M. Curran | 135 | 378 | 30 | 180 | 36 | 493 | |
| Jennifer Baez | 136 | 455 | 28 | 161 | 17 | 580 | |
| Patricia Margaritte‐Jeannin | 216 | 114 | 7 | 36 | 31 | 631 | |
| Giorgio Romanelli | 122 | 455 | 35 | 257 | 34 | 580 | |
| Davide Berlato | 84 | 496 | 26 | 361 | 30 | 597 | |
| Hironobu Sato | 40 | 34 | 21 | 30 | 28 | 509 | |
| M.J. van Zwieten | 55 | 108 | 3 | 34 | 34 | 555 | |
| Jao W | 23 | 77 | 8 | 37 | 21 | 560 | |
| Duncan S. Russell | 31 | 195 | 15 | 92 | 32 | 543 |
All Works
Login with ORCID to disown or claim papers
Loading papers...